Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Pieris Pharmaceuticals Inc (PIRS)

Pieris Pharmaceuticals Inc (PIRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Pieris Pharmaceuticals: Q3 Earnings Snapshot AP - Wed Nov 13, 2024

Pieris Pharmaceuticals: Q3 Earnings Snapshot

PIRS : 13.60 (-15.69%)
Pieris Pharmaceuticals: Q2 Earnings Snapshot AP - Wed Aug 14, 2024

Pieris Pharmaceuticals: Q2 Earnings Snapshot

PIRS : 13.60 (-15.69%)
Pieris Pharmaceuticals: Q1 Earnings Snapshot AP - Wed May 15, 2024

Pieris Pharmaceuticals: Q1 Earnings Snapshot

PIRS : 13.60 (-15.69%)
Pieris Pharmaceuticals: Q3 Earnings Snapshot AP - Tue Nov 14, 2023

Pieris Pharmaceuticals: Q3 Earnings Snapshot

PIRS : 13.60 (-15.69%)
Pieris Pharmaceuticals: Q1 Earnings Snapshot AP - Wed May 10, 2023

Pieris Pharmaceuticals: Q1 Earnings Snapshot

PIRS : 13.60 (-15.69%)
Pieris Pharmaceuticals: Q3 Earnings Snapshot AP - Wed Nov 2, 2022

Pieris Pharmaceuticals: Q3 Earnings Snapshot

PIRS : 13.60 (-15.69%)
Pieris Pharmaceuticals To Present at Jefferies Healthcare Conference ACCESS Newswire - Thu Jun 2, 2022

BOSTON, MA / ACCESSWIRE / June 2, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...

PIRS : 13.60 (-15.69%)
Pieris Pharmaceuticals To Present at H.C. Wainwright Global Investment Conference ACCESS Newswire - Wed May 18, 2022

BOSTON, MA / ACCESSWIRE / May 18, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology...

PIRS : 13.60 (-15.69%)
Pieris Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update ACCESS Newswire - Wed May 11, 2022

Company To Host an Investor Conference Call On Wednesday, May 11, 2022 At 8:00 Am EDT BOSTON, MA / ACCESSWIRE / May 11, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology...

PIRS : 13.60 (-15.69%)
Pieris Pharmaceuticals To Host First Quarter 2022 Investor Call and Provide Corporate Update on May 11, 2022 ACCESS Newswire - Wed May 4, 2022

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

PIRS : 13.60 (-15.69%)

Barchart Exclusives

H&R Block Posted Strong Earnings and Boosted Its Dividend by Nearly 10%. What This Means for HRB Stock. Barchart - Thu Aug 13, 6:30PM CDT
H&R Block beat fiscal fourth-quarter estimates, raised its fiscal 2027 outlook, and increased its quarterly dividend by nearly 10% to $0.46 per share, sending the stock up about 16%. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.